Ignite Creation Date:
2024-05-05 @ 9:41 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00943943
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2009-07-20
Brief Title:
Granulocyte-colony Stimulating Factor G-CSF and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia AML With FLT3 Mutations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| Acute Myelogenous Leukemia |
Keywords:
| Name | View |
|---|---|
| BAY 43-9006 | View |
| acute myelogenous leukemia | View |
| AML | View |
| Leukemia | View |
| myeloid leukemias | View |
| mutated fms-like tyrosine kinase receptor-3 | View |
| FLT3 Mutations | View |
| G-CSF | View |
| Granulocyte Colony Stimulating Factor | View |
| Filgrastim | View |
| Neupogen | View |
| Plerixafor | View |
| Mobozil | View |
| Sorafenib | View |